Package 67877-799-30
Brand: carbamazepine
Generic: carbamazepinePackage Facts
Identity
Package NDC
67877-799-30
Digits Only
6787779930
Product NDC
67877-799
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-799-30)
Marketing
Marketing Status
Brand
carbamazepine
Generic
carbamazepine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f712b540-b6b2-4fc7-a7b4-38b3a8e51964", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "upc": ["0367877799056"], "unii": ["33CM23913M"], "rxcui": ["199378", "402505", "402506"], "spl_set_id": ["f0a254c5-bd33-4b14-b9f0-830b3438f5c6"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-799-01)", "package_ndc": "67877-799-01", "marketing_start_date": "20251101"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-799-05)", "package_ndc": "67877-799-05", "marketing_start_date": "20251101"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-799-30)", "package_ndc": "67877-799-30", "marketing_start_date": "20251101"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (67877-799-33) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "67877-799-33", "marketing_start_date": "20251101"}], "brand_name": "Carbamazepine", "product_id": "67877-799_f712b540-b6b2-4fc7-a7b4-38b3a8e51964", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "67877-799", "generic_name": "Carbamazepine", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "400 mg/1"}], "application_number": "ANDA217277", "marketing_category": "ANDA", "marketing_start_date": "20251101", "listing_expiration_date": "20261231"}